Safety and Effectiveness of Intravenous Belimumab in Patients with Systemic Lupus Erythematosus in South Korea: A Multicentre, Observational, Real-World Study.

Saved in:
Bibliographic Details
Title: Safety and Effectiveness of Intravenous Belimumab in Patients with Systemic Lupus Erythematosus in South Korea: A Multicentre, Observational, Real-World Study.
Authors: Yoo SB; Medical, GSK, Seoul, South Korea., Cho JE; Medical, GSK, Seoul, South Korea., Baek DJ; Medical, GSK, Seoul, South Korea., Lee EB; Medical, GSK, Seoul, South Korea., Park SH; Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Kim SH; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keimyung University, Daegu, South Korea., Lee EY; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Lee YA; Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, South Korea., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang Institute of Bioscience and Biotechnology, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, 04763, South Korea. scbae@hanyang.ac.kr.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 265-278. Date of Electronic Publication: 2026 May 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2199-1154
DOI:10.1007/s40801-026-00556-8